Current location:Home page >> health information

How is ADHD treated?

2026-04-18 00:10:30

ADHD treatments: comprehensive intervention and personalized management

The treatment of attention deficit hyperactivity disorder (ADHD) needs to combine medicine, behavioral intervention and family support. The core methods include drug treatment, psychobehavioral therapy and lifestyle adjustment. Drug treatment mainly uses central nervous system stimulants (such as methylphenidate) and non-stimulants (such as atomoxetine), and strict medical advice must be followed; behavioral therapy improves behavioral problems through cognitive training, parent training, etc.; in terms of lifestyle, regular work and rest, exercise and balanced nutrition are also crucial. Treatment needs to be individualized. There are significant differences between children and adults, and long-term follow-up and evaluation of effects are required.

Drug treatment: scientific drug use and risk control

How is ADHD treated?

First-line medications for ADHD includeMethylphenidate(such as Jingda) andamphetamines(such as Adderall), improves concentration by regulating dopamine and norepinephrine. non-stimulantatomoxetine(Zesta) is suitable for people who are intolerant to stimulants. It has a slower onset but fewer side effects. Medication needs to follow the principle of dose escalation, and common side effects such as loss of appetite and insomnia need to be monitored. New drugs approved by US FDAViloxazine(Qelbree) offers more options for adults. In the Chinese market, Xi'an Janssen's Focuseda and Eli Lilly's Selectda are common brands.

drug typeRepresentative medicineApplicable ageCommon side effects
central stimulantsMethylphenidate (Jianda)6 years and aboveDecreased appetite, palpitations
Non-central stimulantsAtomoxetine (Zesta)6 years and aboveDrowsiness, gastrointestinal reactions

Behavioral intervention: from cognitive training to environmental optimization

Behavioral therapy is especially critical for children with ADHD.Cognitive behavioral therapy (CBT)Helping patients identify impulsive behavior patterns, the American Psychological Association recommends it as an auxiliary treatment for adolescents. Parent training programs such asPT (Parent Training)To teach positive reinforcement techniques, schools can use a token reward system in conjunction. Environmental adjustments include reducing distractions and using tools such as time managers. Research shows that behavioral intervention combined with drug treatment is more effective than single treatment (The Lancet 2015 study).

Lifestyle adjustments: an unnoticed auxiliary force

Regular exercise can improve the function of the prefrontal lobe of the brain. It is recommended to do 30 minutes of aerobic exercise three times a week. dietary supplementOmega-3 fatty acids(fish, flaxseed) may improve symptoms, but the level of evidence is limited. Sleep management is crucial. 60% of ADHD patients have sleep disorders and need to avoid caffeine and fix their bedtime. Mindfulness meditation has also been proven to reduce distractions, with just 10 minutes of daily practice being effective (Harvard Medical School 2018 study).

Treatment Outlook: Multidimensional Integration and Long-Term Management

ADHD treatment requires multi-party collaboration among doctors, families, and schools. Adults with ADHD need to pay attention to comorbidities (such as anxiety and depression), and workplace adaptive training is very important. Emerging therapies such as neurofeedback (EEG biofeedback) are still in the clinical validation stage. Remember, the goal of treatment is not only symptom control, but also to help patients establish a sustainable self-management system. Regular follow-up visits are required to adjust the plan to avoid rebound caused by interruption of treatment.

Quote sources:
1. Diagnostic and Statistical Manual of Mental Disorders (DSM-5) of the American Psychiatric Association
2. "China ADHD Prevention and Treatment Guidelines" by the Pediatric Branch of the Chinese Medical Association
3. Pharmaceutical manufacturers: Xi'an Janssen (Jiangsen), Eli Lilly (Qelbree), Supernus (Qelbree)
4. Research documents: The Lancet Psychiatry (2015), JAMA Pediatrics (2020)

Relevant knowledge

Chinese medicinal materials

More

Friendly links